GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Translational studies of human viruses and chronic neurologic disease

$771,866
Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS

Defining modifiers and mechanisms of RAN translation

$771,846
Joseph D Puglisi · Stanford University · R01 · FY2024 · AG

Surrogate Biomarkers for Disease Progression in IPF

$771,211
Naftali Kaminski · Children'S Hosp Pittsburgh/Upmc Hlth Sys · P50 · FY2008 · HL

Role of TIM-3 in Regulating CNS Autoimmune Responses

$770,454
David A. Hafler · Brigham And Women'S Hospital · P01 · FY2010 · AI

Genetic Epidemiology of Complex Traits

$770,313
Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2010 · HG

MENDELIAN RANDOMIZATION FOR UNBIAS BIOMARKER DISCOVERY FOR AD AND OTHER COMPLEX TRAITS

$769,897
Oscar Harari · Washington University · R01 · FY2019 · AG

Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology

$769,284
Xiaoling Zhang · Boston University Medical Campus · U01 · FY2022 · AG

Para-Vascular Basis of Small Vessel Disease

$769,002
Maiken Nedergaard · University Of Rochester · R01 · FY2017 · NS

Double-stranded RNA in neuronal cell death in Alzheimer's and related neurodegenerative diseases

$768,931
Christopher D Link · University Of Colorado · R01 · FY2024 · AG

Cellular and Genetic Origins of Astrocytes

$768,904
David H Rowitch · University Of California, San Francisco · R01 · FY2010 · NS

The Relationship Between Brain Macrophages and Cognitive Dysfunction in Systemic Lupus Erythematosus

$768,728
Carla M Cuda · Northwestern University At Chicago · R01 · FY2025 · AI

Functions of IL-17 Family Cytokines and their Signaling Mechanisms in Health and Disease

$768,448
Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Validation of a Neurogenic Bladder Management Solution to Promote Independence and Reduce Long-Term Morbidity for Patients Unable to Perform Intermittent Catheterization

$768,122
Christopher Elliott · Crm Medical Devices, Inc. · R44 · FY2022 · DK

MENDELIAN RANDOMIZATION FOR UNBIAS BIOMARKER DISCOVERY FOR AD AND OTHER COMPLEX TRAITS

$767,958
Oscar Harari · Washington University · R01 · FY2020 · AG

MHC Proteins and Human Disease

$767,582
Harvard University · R01 · FY2002 · AI

Diffusion MRI of Complex White Matter and Connectivity

$767,463
Jeremy D Schmahmann · Massachusetts General Hospital · R01 · FY2010 · MH

Integrating Spatial Multi-omics and Clinical Covariates to Identify Mechanisms of Disease in ALS-FTD

$767,453
Hemali Phatnani · New York Genome Center · R01 · FY2023 · NS

A couples-based HIV biobehavioral prevention intervention

$767,402
Omar Martinez · University Of Central Florida · R01 · FY2025 · MD

Autoimmune Encephalitis - Ataxia and Psychiatric Disease: Identifying and Characterizing Novel Antibody Targets

$767,107
Michael R Wilson · University Of California, San Francisco · R01 · FY2023 · MH

Autoimmune Encephalitis - Ataxia and Psychiatric Disease: Identifying and Characterizing Novel Antibody Targets

$767,107
Michael R Wilson · University Of California, San Francisco · R01 · FY2022 · MH

Autoimmune Encephalitis - Ataxia and Psychiatric Disease: Identifying and Characterizing Novel Antibody Targets

$767,107
Michael R Wilson · University Of California, San Francisco · R01 · FY2024 · MH

Autoimmune Encephalitis - Ataxia and Psychiatric Disease: Identifying and Characterizing Novel Antibody Targets

$767,107
Michael R Wilson · University Of California, San Francisco · R01 · FY2021 · MH

Early development of small molecule neuroprotectants.

$767,106
Corinne Ida Lasmezas · Scripps Florida · R01 · FY2020 · NS

Role of Natural Killer Cell Diversity in Multiple Sclerosis Risk and Disease Course

$767,105
Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2022 · AI

Mechanisms and pathophysiologic impact of claudin-2 modulation

$767,016
Jerrold R. Turner · Brigham And Women'S Hospital · R01 · FY2024 · DK